Skip to main content
Erschienen in: European Archives of Oto-Rhino-Laryngology 7/2013

01.07.2013 | Editorial

The changing role of surgery in the current era of head and neck oncology

verfasst von: Alfio Ferlito, Robert P. Takes, Carl E. Silver, Primož Strojan, Missak Haigentz Jr., K. Thomas Robbins, Eric M. Genden, Dana M. Hartl, Ashok R. Shaha, Alessandra Rinaldo, Carlos Suárez, Kerry D. Olsen

Erschienen in: European Archives of Oto-Rhino-Laryngology | Ausgabe 7/2013

Einloggen, um Zugang zu erhalten

Excerpt

As in all fields of scientific endeavor, the nature and role of surgery for treatment of neoplastic disease in the head and neck has evolved since the publication of the first textbook on head and neck surgery by Levi Cooper Lane in 1896 [1]. After the discovery that ionizing radiation could destroy malignant tissue, this modality became a preferred treatment for head and neck cancer because it avoided the massive tissue ablation, infection and other morbidities associated with extirpation of head and neck tumors in the pre-antibiotic era. The initial promise of radiation treatment proved to be disappointing, and by the mid 20th century, ablative surgery with en bloc resection of tumors including wide margins of surrounding normal tissue and the draining lymph node basin could be performed with relative safety and became the preferred standard either as initial treatment or for treatment of irradiation failure [2]. The introduction of megavoltage radiotherapy units in the 1950s and subsequent continuous advances in the fields of radiotherapy technology, radiobiology and drug design led to increased use of irradiation and systemic therapy over time [3]. …
Literatur
1.
Zurück zum Zitat Lane LC (1896) Surgery of Head and Neck. Published by the Author, San Francisco Lane LC (1896) Surgery of Head and Neck. Published by the Author, San Francisco
2.
Zurück zum Zitat Martin H (1957) Surgery of Head and Neck Tumors. Harper and Row, New York Martin H (1957) Surgery of Head and Neck Tumors. Harper and Row, New York
3.
Zurück zum Zitat Fletcher GH (1986) History of irradiation in squamous cell carcinomas of the larynx and hypopharynx. Int J Radiat Oncol Biol Phys 12:2019–2024PubMedCrossRef Fletcher GH (1986) History of irradiation in squamous cell carcinomas of the larynx and hypopharynx. Int J Radiat Oncol Biol Phys 12:2019–2024PubMedCrossRef
4.
Zurück zum Zitat Hartl DM, Brasnu DF, Shah JP, Hinni ML, Takes RP, Olsen KD, Kowalski LP, Rodrigo JP, Strojan P, Wolf GT, Rinaldo A, Suárez C, Mendenhall WM, Paleri V, Forastiere AA, Werner JA, Ferlito A (2013) Is open surgery for head and neck cancers truly declining? Eur Arch Otorhinolaryngol [Epub ahead of print] Hartl DM, Brasnu DF, Shah JP, Hinni ML, Takes RP, Olsen KD, Kowalski LP, Rodrigo JP, Strojan P, Wolf GT, Rinaldo A, Suárez C, Mendenhall WM, Paleri V, Forastiere AA, Werner JA, Ferlito A (2013) Is open surgery for head and neck cancers truly declining? Eur Arch Otorhinolaryngol [Epub ahead of print]
5.
Zurück zum Zitat Suárez C, Rodrigo JP, Silver CE, Hartl DM, Takes RP, Rinaldo A, Strojan P, Ferlito A (2012) Laser surgery for early to moderately advanced glottic, supraglottic, and hypopharyngeal cancers. Head Neck 34:1028–1035PubMedCrossRef Suárez C, Rodrigo JP, Silver CE, Hartl DM, Takes RP, Rinaldo A, Strojan P, Ferlito A (2012) Laser surgery for early to moderately advanced glottic, supraglottic, and hypopharyngeal cancers. Head Neck 34:1028–1035PubMedCrossRef
6.
Zurück zum Zitat van Loon Y, Sjögren EV, Langeveld TP, Baatenburg de Jong RJ, Schoones JW, van Rossum MA (2012) Functional outcomes after radiotherapy or laser surgery in early glottic carcinoma: a systematic review. Head Neck 34:1179–1189PubMedCrossRef van Loon Y, Sjögren EV, Langeveld TP, Baatenburg de Jong RJ, Schoones JW, van Rossum MA (2012) Functional outcomes after radiotherapy or laser surgery in early glottic carcinoma: a systematic review. Head Neck 34:1179–1189PubMedCrossRef
7.
Zurück zum Zitat Genden EM, O’Malley BW Jr, Weinstein GS, Stucken CL, Selber JC, Rinaldo A, Hockstein NG, Ozer E, Mallet Y, Satava RM, Moore EJ, Silver CE, Ferlito A (2012) Transoral robotic surgery: role in the management of upper aerodigestive tract tumors. Head Neck 34:886–893PubMedCrossRef Genden EM, O’Malley BW Jr, Weinstein GS, Stucken CL, Selber JC, Rinaldo A, Hockstein NG, Ozer E, Mallet Y, Satava RM, Moore EJ, Silver CE, Ferlito A (2012) Transoral robotic surgery: role in the management of upper aerodigestive tract tumors. Head Neck 34:886–893PubMedCrossRef
8.
Zurück zum Zitat Genden EM, Sambur IM, de Almeida JR, Posner M, Rinaldo A, Rodrigo JP, Strojan P, Takes RP, Ferlito A (2012) Human papillomavirus and oropharyngeal squamous cell carcinoma: what the clinician should know. Eur Arch Otorhinolaryngol [Epub ahead of print] Genden EM, Sambur IM, de Almeida JR, Posner M, Rinaldo A, Rodrigo JP, Strojan P, Takes RP, Ferlito A (2012) Human papillomavirus and oropharyngeal squamous cell carcinoma: what the clinician should know. Eur Arch Otorhinolaryngol [Epub ahead of print]
9.
Zurück zum Zitat Haigentz M Jr, Silver CE, Corry J, Genden EM, Takes RP, Rinaldo A, Ferlito A (2009) Current trends in initial management of oropharyngeal cancer: the declining use of open surgery. Eur Arch Otorhinolaryngol 266:1845–1855PubMedCrossRef Haigentz M Jr, Silver CE, Corry J, Genden EM, Takes RP, Rinaldo A, Ferlito A (2009) Current trends in initial management of oropharyngeal cancer: the declining use of open surgery. Eur Arch Otorhinolaryngol 266:1845–1855PubMedCrossRef
10.
Zurück zum Zitat Yoshizaki T, Ito M, Murono S, Wakisaka N, Kondo S, Endo K (2012) Current understanding and management of nasopharyngeal carcinoma. Auris Nasus Larynx 39:137–144PubMedCrossRef Yoshizaki T, Ito M, Murono S, Wakisaka N, Kondo S, Endo K (2012) Current understanding and management of nasopharyngeal carcinoma. Auris Nasus Larynx 39:137–144PubMedCrossRef
11.
Zurück zum Zitat Strojan P, Haigentz M Jr, Bradford CR, Wolf GT, Hartl D, Langendijk JA, Rinaldo A, Eisbruch A, Mendenhall WM, Forastiere AA, Takes RP, Ferlito A (2012) Chemoradiotherapy vs. total laryngectomy for primary treatment of advanced laryngeal squamous cell carcinoma. Oral Oncol [Epub ahead of print] Strojan P, Haigentz M Jr, Bradford CR, Wolf GT, Hartl D, Langendijk JA, Rinaldo A, Eisbruch A, Mendenhall WM, Forastiere AA, Takes RP, Ferlito A (2012) Chemoradiotherapy vs. total laryngectomy for primary treatment of advanced laryngeal squamous cell carcinoma. Oral Oncol [Epub ahead of print]
12.
Zurück zum Zitat Takes RP, Strojan P, Silver CE, Bradley PJ, Haigentz M Jr, Wolf GT, Shaha AR, Hartl DM, Olofsson J, Langendijk JA, Rinaldo A, Ferlito A (2012) Current trends in initial management of hypopharyngeal cancer: the declining use of open surgery. Head Neck 34:270–281PubMedCrossRef Takes RP, Strojan P, Silver CE, Bradley PJ, Haigentz M Jr, Wolf GT, Shaha AR, Hartl DM, Olofsson J, Langendijk JA, Rinaldo A, Ferlito A (2012) Current trends in initial management of hypopharyngeal cancer: the declining use of open surgery. Head Neck 34:270–281PubMedCrossRef
13.
Zurück zum Zitat Licitra L, Grandi C, Guzzo M, Mariani L, Lo Vullo S, Valvo F, Quattrone P, Valagussa P, Bonadonna G, Molinari R, Cantù G (2003) Primary chemotherapy in resectable oral cavity squamous cell cancer: a randomized controlled trial. J Clin Oncol 21:327–333 Licitra L, Grandi C, Guzzo M, Mariani L, Lo Vullo S, Valvo F, Quattrone P, Valagussa P, Bonadonna G, Molinari R, Cantù G (2003) Primary chemotherapy in resectable oral cavity squamous cell cancer: a randomized controlled trial. J Clin Oncol 21:327–333
14.
Zurück zum Zitat Stenson KM, Kunnavakkam R, Cohen EE, Portugal LD, Blair E, Haraf DJ, Salama J, Vokes EE (2010) Chemoradiation for patients with advanced oral cavity cancer. Laryngoscope 120:93–99PubMedCrossRef Stenson KM, Kunnavakkam R, Cohen EE, Portugal LD, Blair E, Haraf DJ, Salama J, Vokes EE (2010) Chemoradiation for patients with advanced oral cavity cancer. Laryngoscope 120:93–99PubMedCrossRef
15.
Zurück zum Zitat Machtay M, Moughan J, Trotti A, Garden AS, Weber RS, Cooper JS, Forastiere A, Ang KK (2008) Factors associated with severe late toxicity after concurrent chemoradiation for locally advanced head and neck cancer: an RTOG analysis. J Clin Oncol 26:3582–3589PubMedCrossRef Machtay M, Moughan J, Trotti A, Garden AS, Weber RS, Cooper JS, Forastiere A, Ang KK (2008) Factors associated with severe late toxicity after concurrent chemoradiation for locally advanced head and neck cancer: an RTOG analysis. J Clin Oncol 26:3582–3589PubMedCrossRef
16.
Zurück zum Zitat Paleri V, Roe JWG, Strojan P, Corry J, Gregoire V, Hamoir M, Eisbruch A, Mendenhall WM, Silver CE, Rinaldo A, Takes RP, Ferlito A (2013) Strategies to reduce long term postchemoradiation dysphagia in patients with head and neck cancer: an evidence based review. Head Neck (in press) Paleri V, Roe JWG, Strojan P, Corry J, Gregoire V, Hamoir M, Eisbruch A, Mendenhall WM, Silver CE, Rinaldo A, Takes RP, Ferlito A (2013) Strategies to reduce long term postchemoradiation dysphagia in patients with head and neck cancer: an evidence based review. Head Neck (in press)
17.
Zurück zum Zitat Wang ZH, Zhang SZ, Zhang ZY, Zhang CP, Hu HS, Tu WY, Kirwan J, Mendenhall WM (2012) Protecting the oral mucosa in patients with oral tongue squamous cell carcinoma treated postoperatively with intensity-modulated radiotherapy: a randomized study. Laryngoscope 122:291–298PubMedCrossRef Wang ZH, Zhang SZ, Zhang ZY, Zhang CP, Hu HS, Tu WY, Kirwan J, Mendenhall WM (2012) Protecting the oral mucosa in patients with oral tongue squamous cell carcinoma treated postoperatively with intensity-modulated radiotherapy: a randomized study. Laryngoscope 122:291–298PubMedCrossRef
18.
Zurück zum Zitat Nutting CM, Morden JP, Harrington KJ, Urbano TG, Bhide SA, Clark C, Miles EA, Miah AB, Newbold K, Tanay M, Adab F, Jefferies SJ, Scrase C, Yap BK, A’Hern RP, Sydenham MA, Emson M, Hall E; PARSPORT trial management group (2011) Parotid-sparing intensity modulated versus conventional radiotherapy in head and neck cancer (PARSPORT): a phase 3 multicentre randomised controlled trial. Lancet Oncol 12:127–136 Nutting CM, Morden JP, Harrington KJ, Urbano TG, Bhide SA, Clark C, Miles EA, Miah AB, Newbold K, Tanay M, Adab F, Jefferies SJ, Scrase C, Yap BK, A’Hern RP, Sydenham MA, Emson M, Hall E; PARSPORT trial management group (2011) Parotid-sparing intensity modulated versus conventional radiotherapy in head and neck cancer (PARSPORT): a phase 3 multicentre randomised controlled trial. Lancet Oncol 12:127–136
Metadaten
Titel
The changing role of surgery in the current era of head and neck oncology
verfasst von
Alfio Ferlito
Robert P. Takes
Carl E. Silver
Primož Strojan
Missak Haigentz Jr.
K. Thomas Robbins
Eric M. Genden
Dana M. Hartl
Ashok R. Shaha
Alessandra Rinaldo
Carlos Suárez
Kerry D. Olsen
Publikationsdatum
01.07.2013
Verlag
Springer-Verlag
Erschienen in
European Archives of Oto-Rhino-Laryngology / Ausgabe 7/2013
Print ISSN: 0937-4477
Elektronische ISSN: 1434-4726
DOI
https://doi.org/10.1007/s00405-013-2353-z

Weitere Artikel der Ausgabe 7/2013

European Archives of Oto-Rhino-Laryngology 7/2013 Zur Ausgabe

Kinder mit anhaltender Sinusitis profitieren häufig von Antibiotika

30.04.2024 Rhinitis und Sinusitis Nachrichten

Persistieren Sinusitisbeschwerden bei Kindern länger als zehn Tage, ist eine Antibiotikatherapie häufig gut wirksam: Ein Therapieversagen ist damit zu über 40% seltener zu beobachten als unter Placebo.

CUP-Syndrom: Künstliche Intelligenz kann Primärtumor finden

30.04.2024 Künstliche Intelligenz Nachrichten

Krebserkrankungen unbekannten Ursprungs (CUP) sind eine diagnostische Herausforderung. KI-Systeme können Pathologen dabei unterstützen, zytologische Bilder zu interpretieren, um den Primärtumor zu lokalisieren.

Sind Frauen die fähigeren Ärzte?

30.04.2024 Gendermedizin Nachrichten

Patienten, die von Ärztinnen behandelt werden, dürfen offenbar auf bessere Therapieergebnisse hoffen als Patienten von Ärzten. Besonders gilt das offenbar für weibliche Kranke, wie eine Studie zeigt.

Akuter Schwindel: Wann lohnt sich eine MRT?

28.04.2024 Schwindel Nachrichten

Akuter Schwindel stellt oft eine diagnostische Herausforderung dar. Wie nützlich dabei eine MRT ist, hat eine Studie aus Finnland untersucht. Immerhin einer von sechs Patienten wurde mit akutem ischämischem Schlaganfall diagnostiziert.

Update HNO

Bestellen Sie unseren Fach-Newsletter und bleiben Sie gut informiert – ganz bequem per eMail.